CD44 and colorectal cancer: This was further confirmed by flow cytometry analysis, showing that FUT9 silencing decreases the expression of a prominent colorectal cancer TIC marker CD44 (Dalerba et al, 2007; Qureshi‐Baig et al, 2017) in HCT116 cells (Fig 4C).